This topic contains a solution. Click here to go to the answer

Author Question: The KABC a. tends to show larger African-American/white differences than the WISC-R or Binet. b. ... (Read 136 times)

savannahhooper

  • Hero Member
  • *****
  • Posts: 576
The KABC
 
  a. tends to show larger African-American/white differences than the WISC-R or Binet.
  b. tends to show smaller African-American/white differences than the WISC-R or Binet.
  c. is not appropriate for evaluating African-American children.
  d. is not appropriate for evaluating white children.

Question 2

A student stays up all night studying for a test. She is so exhausted that she does not perform well even though she has learned the content for the test. This is an example of
 
  a. poor construct validity.
  b. predictive validity evidence.
  c. construct-irrelevant invariance.
  d. construct underrepresentation .



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tashiedavis420

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

b

Answer to Question 2

c




savannahhooper

  • Member
  • Posts: 576
Reply 2 on: Jun 19, 2018
Gracias!


dawsa925

  • Member
  • Posts: 326
Reply 3 on: Yesterday
Excellent

 

Did you know?

For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

Did you know?

The ratio of hydrogen atoms to oxygen in water (H2O) is 2:1.

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library